These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experiences in the treatment of bronchospastic diseases]. Klein HG Med Welt; 1967 Nov; 45():2718-21. PubMed ID: 5609213 [No Abstract] [Full Text] [Related]
3. An effective oral medication for long term bronchodilation. Levine ER Ann Allergy; 1965 Sep; 23(9):403-13. PubMed ID: 5830236 [No Abstract] [Full Text] [Related]
5. A niacinamide-theophylline compound (RC-C-144). II. Clinical and spirometric effects. Cohen BM J Asthma Res; 1966 Sep; 4(1):81-7. PubMed ID: 4224926 [No Abstract] [Full Text] [Related]
6. A niacinamide-theophylline compound (RC-C-144). I. Human absorption and blood level studies. Cohen BM J Asthma Res; 1966 Sep; 4(1):75-9. PubMed ID: 4224925 [No Abstract] [Full Text] [Related]
7. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form]. Pollert I Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500 [No Abstract] [Full Text] [Related]
8. [The spirographically controlled treatment of the chronic nonspecific respiratory syndrome]. Pichler O Wien Med Wochenschr; 1971 Mar; 121(12):223-6. PubMed ID: 5556377 [No Abstract] [Full Text] [Related]
9. [Treatment of the chronic bronchitic syndrome with Ozothine]. Nonhoff R Med Monatsschr; 1967 Aug; 21(8):367-70. PubMed ID: 5597098 [No Abstract] [Full Text] [Related]
10. [Clinical experiences with a new drug association with anti-asthmatic action]. Martelli A Clin Ter; 1967 Jun; 41(6):529-44. PubMed ID: 4387419 [No Abstract] [Full Text] [Related]
11. [Nebetol in the treatment of bronchial asthma and chronic obstructive bronchitis]. Popovac D; Spasić P; Vukcević G Plucne Bolesti; 1985; 37(1-2):106-9. PubMed ID: 3906721 [No Abstract] [Full Text] [Related]
12. [Clinical experiences with delayed action Perspiran in obstructive respratory disorders]. Dlouhy R Med Welt; 1967 Aug; 33():1918-21. PubMed ID: 5590200 [No Abstract] [Full Text] [Related]
13. Airway responsiveness in chronic obstructive pulmonary disease. Payne CB; Chester EH; Hsi BP Am J Med; 1967 Apr; 42(4):554-66. PubMed ID: 6023002 [No Abstract] [Full Text] [Related]
14. Bioavailability and efficacy of a sustained-release theophylline tablet. Mitenko PA; Ogilvie RI Clin Pharmacol Ther; 1974 Oct; 16(4):720-6. PubMed ID: 4609343 [No Abstract] [Full Text] [Related]
15. [Factory physician and bronchitis]. Hansen P Z Allgemeinmed; 1969 Jan; 45(1):33-5. PubMed ID: 5772370 [No Abstract] [Full Text] [Related]
16. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms]. Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401 [No Abstract] [Full Text] [Related]
17. [The treatment of bronchial asthma and the combination treatment of acute and chronic bronchial, bronchopulmonary and pulmonary infections with Asthma 23D. An experience report of medical practice during the time period of 5 years]. Wendt H Wien Med Wochenschr; 1966 Jul; 116(28):634-7. PubMed ID: 5995268 [No Abstract] [Full Text] [Related]
18. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ; Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682 [TBL] [Abstract][Full Text] [Related]
19. [Clinical experiences with a new bronchodilator agent (Marax)]. Paul K Wien Med Wochenschr; 1969 Mar; 119(13):252-3. PubMed ID: 5767543 [No Abstract] [Full Text] [Related]